Report error Found 213 Enz. Inhib. hit(s) with all data for entry = 12956
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 10nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 10nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 15nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 17nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 20nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 20nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 21nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 21nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 21nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 22nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 23nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 23nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 24nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 24nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 24nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 25nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 26nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 26nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 29nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 29nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 30nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 30nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 30nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 31nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 31nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 31nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 31nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 32nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 32nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 33nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 34nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 34nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 35nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 36nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 38nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 39nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 39nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 40nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 40nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 41nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 41nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 42nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 43nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 43nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 44nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 44nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 44nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 44nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 45nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair
TargetSodium-dependent neutral amino acid transporter B(0)AT1(Human)
Mitsubishi Tanabe Pharma
US Patent
Mitsubishi Tanabe Pharma
US Patent
Affinity DataIC50: 46nMAssay Description:A test compound dissolved in dimethyl sulfoxide (DMSO) was added to a 96 well plate for solid phase radioactivity measurement containing a scintillat...More data for this Ligand-Target Pair

















































